BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2290
-0.0009 (-0.39%)
Apr 27, 2026, 2:04 PM EDT - Market open
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $5.83 million as of April 27, 2026. Its market cap has decreased by -57.72% in one year.
Market Cap
5.83M
Enterprise Value
2.95M
1-Year Change
-57.72%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has decreased from $6.50M to $5.83M, a decrease of -10.24%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 5.90M | -43.27% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 6.45M |
| XTL Biopharmaceuticals | 6.33M |
| Purple Biotech | 6.23M |
| CollPlant Biotechnologies | 6.00M |
| Aptevo Therapeutics | 5.76M |
| Mustang Bio | 5.71M |
| Ernexa Therapeutics | 5.59M |
| PMGC Holdings | 5.48M |